Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 2, 2018PLoS ONEOpen Access

Intravenously delivered mesenchymal stem cell-derived exosomes target M2-type macrophages in the injured spinal cord

View Full Paper
Ask AI
Bookmark
Share

Authors

KLKaren L. LankfordYale UniversityEAEdgardo J. ArroyoUniversity of PennsylvaniaKNKatarzyna NazimekJagiellonian University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lankford et al. (2018) studied this question.

synapsesocial.com/papers/69dbed7940b636d1dda3c52fhttps://doi.org/10.1371/journal.pone.0190358
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A role for spleen monocytes in post-ischemic brain inflammation and injury2010 · 95 citations
  2. 2Spinal cord injury‐induced immune depression syndrome (SCI‐IDS)2007 · 146 citations
  3. 3Mesenchymal Stem/Stromal Cells (MSCs): Role as Guardians of Inflammation2011 · 831 citations
  4. 4Delayed Imatinib Treatment for Acute Spinal Cord Injury: Functional Recovery and Serum Biomarkers2015 · 24 citations
  5. 5A Pericyte Origin of Spinal Cord Scar Tissue2011 · 868 citations